We understand how short on time everyone is, with this in mind we are rolling out a series of clinical microbiology focussed talks that will be no longer than an hour in length. These will also be recorded individually and after each event a link will be sent out to those who signed up.
We continue our series with a talk from Dr Sarah Copsey-Mawer.
Talk: New anaerobes for EUCAST guidance in 2026: Identification, significance, and advice
Dr Sarah Copsey-Mawer:
MBBS MD (Microbiology)
Senior Biomedical Scientist, UK Anaerobe Reference Unit, Cardiff, Wales
Sarah is a Senior Biomedical Scientist at the UK Anaerobe Reference Unit (UKARU) where she has led on the incorporation into service of both MALDI-TOF MS and gold standard AST by agar dilution. Sarah has overseen the implementation of EUCAST disk diffusion AST of anaerobes across Wales as part of ongoing EUCAST developments for improving AST methods and guidance for anaerobes.
She is currently co- chair of the CLSI working group for Anaerobe AST and a committee member of the Society for Anaerobic Microbiology (SAM). Sarah has also co-authored several papers and contributed to chapters for CLSI, MCM and CMPH.
